Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
6,119
Funds Holding Change
-4
Funds Holding Growth
-0.1%
Value
$1.99T
Holding in Top 10
1,061
Top 10 Change
+142
Top 10 Growth
+15%
Value Growth
+13%
New
261
Increased
2,706
Reduced
2,804
Closed
160
Capital Inflow
$378B
Capital Outflow
$84.2B
Net Capital Flow
+$294B
Capital Flow Change
+$231B
Calls
$25B
Puts
$22.1B
Net Calls
+$2.9B
Put/Call Ratio
0.88